[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Consumer Health in Switzerland

November 2023 | 107 pages | ID: C6B569C8EAFEN
Euromonitor International Ltd

US$ 2,650.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Consumer health witnessed a solid performance in 2023, with current value growth gaining momentum for the fourth consecutive year. Overall there has been little change in the price of OTC products, despite the slightly higher inflation rate in 2023, although there has been some bottlenecks in the supply chain with shortages occurring at times.

Euromonitor International's Consumer Health in Switzerland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Consumer Health market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Consumer Health in Switzerland
Euromonitor International
November 2023
List Of Contents And Tables
CONSUMER HEALTH IN SWITZERLAND
EXECUTIVE SUMMARY
Consumer health in 2023: The big picture

2023 KEY TRENDS

Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2018-2023
Table 2 Life Expectancy at Birth 2018-2023
MARKET DATA
Table 3 Sales of Consumer Health by Category: Value 2018-2023
Table 4 Sales of Consumer Health by Category: % Value Growth 2018-2023
Table 5 NBO Company Shares of Consumer Health: % Value 2019-2023
Table 6 LBN Brand Shares of Consumer Health: % Value 2020-2023
Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2018-2023
Table 8 Distribution of Consumer Health by Format: % Value 2018-2023
Table 9 Distribution of Consumer Health by Format and Category: % Value 2023
Table 10 Forecast Sales of Consumer Health by Category: Value 2023-2028
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2023-2028
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2022-2023
DISCLAIMER
DEFINITIONS
SOURCES
Summary 2 Research Sources
ANALGESICS IN SWITZERLAND
KEY DATA FINDINGS

2023 DEVELOPMENTS

Analgesics enjoys slight rebound in sales volume
Topical analgesics are cannibalising sales of diclofenac
Dafalgan leads analgesics category
PROSPECTS AND OPPORTUNITIES
Steady growth trajectory for analgesics
Rising consumer interest in herbal and natural alternatives
Dafalgan expected to maintain its lead in analgesics
CATEGORY DATA
Table 12 Sales of Analgesics by Category: Value 2018-2023
Table 13 Sales of Analgesics by Category: % Value Growth 2018-2023
Table 14 NBO Company Shares of Analgesics: % Value 2019-2023
Table 15 LBN Brand Shares of Analgesics: % Value 2020-2023
Table 16 Forecast Sales of Analgesics by Category: Value 2023-2028
Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2023-2028
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN SWITZERLAND
KEY DATA FINDINGS

2023 DEVELOPMENTS

Stronger performance driven by higher incidence of allergies and common viruses
Medicated confectionery witnesses the best performance in 2023
Multinational players compete alongside local companies
PROSPECTS AND OPPORTUNITIES
Moderate growth in mature cough, cold and allergy (hay fever) remedies category
Consumers keen to try herbal/traditional remedies
E-commerce to facilitate future sales development
CATEGORY DATA
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2018-2023
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2018-2023
Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2019-2023
Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2020-2023
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2023-2028
Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2023-2028
DIGESTIVE REMEDIES IN SWITZERLAND
KEY DATA FINDINGS

2023 DEVELOPMENTS

Busy lifestyles outside the home underpins stronger growth
On-the-go lifestyles spur sales of antacids
Imodium leads digestive remedies category
PROSPECTS AND OPPORTUNITIES
Maturity and healthier lifestyles to reduce demand for digestive remedies
Herbal/traditional digestive remedies offers new sales opportunities
E-commerce faces growth potential
CATEGORY DATA
Table 24 Sales of Digestive Remedies by Category: Value 2018-2023
Table 25 Sales of Digestive Remedies by Category: % Value Growth 2018-2023
Table 26 NBO Company Shares of Digestive Remedies: % Value 2019-2023
Table 27 LBN Brand Shares of Digestive Remedies: % Value 2020-2023
Table 28 Forecast Sales of Digestive Remedies by Category: Value 2023-2028
Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2023-2028
DERMATOLOGICALS IN SWITZERLAND
KEY DATA FINDINGS

2023 DEVELOPMENTS

Dermatologicals sees growth rebound in 2023
Antipruritics demand is driven by ageing population
Bayer (Schweiz) AG leads in dermatologicals
PROSPECTS AND OPPORTUNITIES
Dermatologicals to enjoy steady value growth
Trend for natural products will somewhat suppress stronger growth in traditional dermatologicals
Multinationals to lead in dermatologicals
CATEGORY DATA
Table 30 Sales of Dermatologicals by Category: Value 2018-2023
Table 31 Sales of Dermatologicals by Category: % Value Growth 2018-2023
Table 32 NBO Company Shares of Dermatologicals: % Value 2019-2023
Table 33 LBN Brand Shares of Dermatologicals: % Value 2020-2023
Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2020-2023
Table 35 Forecast Sales of Dermatologicals by Category: Value 2023-2028
Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2023-2028
NRT SMOKING CESSATION AIDS IN SWITZERLAND
KEY DATA FINDINGS

2023 DEVELOPMENTS

NRT smoking cessation sales gain ground
NRT gum and patches outperform other categories
Janssen-Cilag AG maintains category leadership
PROSPECTS AND OPPORTUNITIES
Steady and slow progress ahead for NRT smoking cessation aids
Innovation expected in flavours and packaging, to compete with the rising trends for vaping and heated tobacco
Sustainability concerns and advertising will encourage smoking cessation
CATEGORY INDICATORS
Table 37 Number of Smokers by Gender 2018-2023
CATEGORY DATA
Table 38 Sales of NRT Smoking Cessation Aids by Category: Value 2018-2023
Table 39 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2018-2023
Table 40 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2019-2023
Table 41 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2020-2023
Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2023-2028
Table 43 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2023-2028
SLEEP AIDS IN SWITZERLAND
KEY DATA FINDINGS

2023 DEVELOPMENTS

Rising stress levels drive sales of sleep aids
Natural alternatives to support sleep on the increase
Sidroga AG maintains lead in sleep aids
PROSPECTS AND OPPORTUNITIES
Growth to slow with anxiety and stress causing sleep disturbances
Sustained focus on natural products and more segmentation expected
No change in distribution channels expected in the short-term, but longer-term prospects may change sales landscape
CATEGORY DATA
Table 44 Sales of Sleep Aids: Value 2018-2023
Table 45 Sales of Sleep Aids: % Value Growth 2018-2023
Table 46 NBO Company Shares of Sleep Aids: % Value 2019-2023
Table 47 LBN Brand Shares of Sleep Aids: % Value 2020-2023
Table 48 Forecast Sales of Sleep Aids: Value 2023-2028
Table 49 Forecast Sales of Sleep Aids: % Value Growth 2023-2028
EYE CARE IN SWITZERLAND
KEY DATA FINDINGS

2023 DEVELOPMENTS

Allergies and screen time supports sales of eye care
Prevalence of allergies fuels sales of allergy eye care
Thйa Pharma SA maintains its overall lead as Collypan from Verfora becomes top brand
PROSPECTS AND OPPORTUNITIES
Eye care to witness steady growth
Climate change and pollution to drive need for allergy eye care
Category saturation and maturity poses challenges for players
CATEGORY DATA
Table 50 Sales of Eye Care by Category: Value 2018-2023
Table 51 Sales of Eye Care by Category: % Value Growth 2018-2023
Table 52 NBO Company Shares of Eye Care: % Value 2019-2023
Table 53 LBN Brand Shares of Eye Care: % Value 2020-2023
Table 54 Forecast Sales of Eye Care by Category: Value 2023-2028
Table 55 Forecast Sales of Eye Care by Category: % Value Growth 2023-2028
WOUND CARE IN SWITZERLAND
KEY DATA FINDINGS

2023 DEVELOPMENTS

Travel and tourism gives wound care sales a lift
Branded wound care and private label compete head on
Ageing population and outdoor activities support wound care
PROSPECTS AND OPPORTUNITIES
Wound care products to enjoy slow and steady growth
First aid kits to become the norm in homes as well as cars
Innovation to remain key as brands and private label compete fiercely
CATEGORY DATA
Table 56 Sales of Wound Care by Category: Value 2018-2023
Table 57 Sales of Wound Care by Category: % Value Growth 2018-2023
Table 58 NBO Company Shares of Wound Care: % Value 2019-2023
Table 59 LBN Brand Shares of Wound Care: % Value 2020-2023
Table 60 Forecast Sales of Wound Care by Category: Value 2023-2028
Table 61 Forecast Sales of Wound Care by Category: % Value Growth 2023-2028
VITAMINS IN SWITZERLAND
KEY DATA FINDINGS

2023 DEVELOPMENTS

Demand for vitamins remains strong post-pandemic
New formats make taking vitamins fun and practical
Swiss consumers still prefer to shop offline
PROSPECTS AND OPPORTUNITIES
Personalised vitamins to support the health and wellness agenda
Extending the customer experience into the digital world
A more focused and strategic approach to vitamin consumption
CATEGORY DATA
Table 62 Sales of Vitamins by Category: Value 2018-2023
Table 63 Sales of Vitamins by Category: % Value Growth 2018-2023
Table 64 Sales of Multivitamins by Positioning: % Value 2018-2023
Table 65 NBO Company Shares of Vitamins: % Value 2019-2023
Table 66 LBN Brand Shares of Vitamins: % Value 2020-2023
Table 67 Forecast Sales of Vitamins by Category: Value 2023-2028
Table 68 Forecast Sales of Vitamins by Category: % Value Growth 2023-2028
DIETARY SUPPLEMENTS IN SWITZERLAND
KEY DATA FINDINGS

2023 DEVELOPMENTS

The ageing Swiss population looks to dietary supplements as preventative care
Burgerstein maintains its lead in Swiss dietary supplements
Store-based retail witnesses biggest growth as consumers prefer to buy in-store
PROSPECTS AND OPPORTUNITIES
Personalisation is growing to meet specific consumer needs
Women’s health supplementation on upward growth trajectory
Green products to experience growth in forecast period
CATEGORY DATA
Table 69 Sales of Dietary Supplements by Category: Value 2018-2023
Table 70 Sales of Dietary Supplements by Category: % Value Growth 2018-2023
Table 71 Sales of Dietary Supplements by Positioning: % Value 2018-2023
Table 72 NBO Company Shares of Dietary Supplements: % Value 2019-2023
Table 73 LBN Brand Shares of Dietary Supplements: % Value 2020-2023
Table 74 Forecast Sales of Dietary Supplements by Category: Value 2023-2028
Table 75 Forecast Sales of Dietary Supplements by Category: % Value Growth 2023-2028
WEIGHT MANAGEMENT AND WELLBEING IN SWITZERLAND
KEY DATA FINDINGS

2023 DEVELOPMENTS

Steady value growth even as consumers make cutbacks due to cost of living crisis
Convenience and natural trend support sales
Direct sales channel sees buoyant performance
PROSPECTS AND OPPORTUNITIES
Natural alternatives to gain popularity
Demand for sustainable and ethical products expected to rise
Digital technologies open up new opportunities
CATEGORY DATA
Table 76 Sales of Weight Management and Wellbeing by Category: Value 2018-2023
Table 77 Sales of Weight Management and Wellbeing by Category: % Value Growth 2018-2023
Table 78 NBO Company Shares of Weight Management and Wellbeing: % Value 2019-2023
Table 79 LBN Brand Shares of Weight Management and Wellbeing: % Value 2020-2023
Table 80 Forecast Sales of Weight Management and Wellbeing by Category: Value 2023-2028
Table 81 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2023-2028
SPORTS NUTRITION IN SWITZERLAND
KEY DATA FINDINGS

2023 DEVELOPMENTS

Protein powders gain wider appeal in sports nutrition
Wider distribution of all types of sports nutrition due to mass demand
E-commerce sales remain key even as retailers expand stocks in-store
PROSPECTS AND OPPORTUNITIES
More convenient formats to support sales growth
Brands can capitalise on rise of athlete celebrities
Consumers to be attracted by affordable options
CATEGORY DATA
Table 82 Sales of Sports Nutrition by Category: Value 2018-2023
Table 83 Sales of Sports Nutrition by Category: % Value Growth 2018-2023
Table 84 NBO Company Shares of Sports Nutrition: % Value 2019-2023
Table 85 LBN Brand Shares of Sports Nutrition: % Value 2020-2023
Table 86 Forecast Sales of Sports Nutrition by Category: Value 2023-2028
Table 87 Forecast Sales of Sports Nutrition by Category: % Value Growth 2023-2028
HERBAL/TRADITIONAL PRODUCTS IN SWITZERLAND
KEY DATA FINDINGS

2023 DEVELOPMENTS

Upbeat performance in herbal/traditional products
Procter & Gamble maintains lead with Vicks brand, in a highly fragmented category
Herbal topical analgesics gain appeal as consumers seek to avoid taking oral medications
PROSPECTS AND OPPORTUNITIES
Sales to be supported by ongoing health and wellness trends
Influencer marketing on social media likely to gain traction
Herbal/traditional topical analgesics to grow from a small base
CATEGORY DATA
Table 88 Sales of Herbal/Traditional Products by Category: Value 2018-2023
Table 89 Sales of Herbal/Traditional Products by Category: % Value Growth 2018-2023
Table 90 NBO Company Shares of Herbal/Traditional Products: % Value 2019-2023
Table 91 LBN Brand Shares of Herbal/Traditional Products: % Value 2020-2023
Table 92 Forecast Sales of Herbal/Traditional Products by Category: Value 2023-2028
Table 93 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2023-2028
PAEDIATRIC CONSUMER HEALTH IN SWITZERLAND
KEY DATA FINDINGS

2023 DEVELOPMENTS

Paediatrics enjoys steady growth as parents prioritise children’s health
Galderma remains the leading player in paediatric consumer health
Paediatric VDS is a popular option in paediatric category
PROSPECTS AND OPPORTUNITIES
Flat growth expected over the forecast period, due to ongoing parental caution
Paediatric analgesics face further decline
Paediatric VDS to enjoy fastest growth
CATEGORY DATA
Table 94 Sales of Paediatric Consumer Health by Category: Value 2018-2023
Table 95 Sales of Paediatric Consumer Health by Category: % Value Growth 2018-2023
Table 96 NBO Company Shares of Paediatric Consumer Health: % Value 2019-2023
Table 97 LBN Brand Shares of Paediatric Consumer Health: % Value 2020-2023
Table 98 Forecast Sales of Paediatric Consumer Health by Category: Value 2023-2028
Table 99 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2023-2028


More Publications